{
  "DOI": "10.1007/s00439-011-1130-6",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-011-1130-6",
  "alternative-id": [
    "1130"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Cuisset",
      "given": "Thomas",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Morange",
      "given": "Pierre-Emmanuel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Alessi",
      "given": "Marie-Christine",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        12,
        29
      ]
    ],
    "date-time": "2011-12-29T10:18:49Z",
    "timestamp": 1325153929000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        6,
        12
      ]
    ],
    "date-time": "2023-06-12T16:54:03Z",
    "timestamp": 1686588843000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        22
      ]
    ],
    "date-time": "2023-11-22T07:23:54Z",
    "timestamp": 1700637834226
  },
  "is-referenced-by-count": 22,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2011,
        12,
        30
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2012,
          5
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2011,
            12,
            30
          ]
        ],
        "date-time": "2011-12-30T00:00:00Z",
        "timestamp": 1325203200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-011-1130-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-011-1130-6/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-011-1130-6",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "653-664",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2011,
        12,
        30
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        12,
        30
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2012,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.jcin.2010.12.011",
      "author": "D Alexopoulos",
      "doi-asserted-by": "crossref",
      "first-page": "403",
      "journal-title": "JACC Cardiovasc Interv",
      "key": "1130_CR1",
      "unstructured": "Alexopoulos D, Dimitropoulos G, Davlouros P, Xanthopoulou I, Kassimis G, Stavrou EF, Hahalis G, Athanassiadou A (2011) Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping. JACC Cardiovasc Interv 4:403–410",
      "volume": "4",
      "year": "2011"
    },
    {
      "DOI": "10.1097/01.mbc.0000114439.81125.86",
      "author": "DJ Angiolillo",
      "doi-asserted-by": "crossref",
      "first-page": "427",
      "journal-title": "Blood Coagul Fibrinolysis",
      "key": "1130_CR2",
      "unstructured": "Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Escaned J, Moreno R, Hernández-Antolin R, Sabaté M, Trabetti E, Pignatti PF, Macaya C (2004) 807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment. Blood Coagul Fibrinolysis 15:427–433",
      "volume": "15",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.thromres.2005.03.001",
      "author": "DJ Angiolillo",
      "doi-asserted-by": "crossref",
      "first-page": "491",
      "journal-title": "Thromb Res",
      "key": "1130_CR3",
      "unstructured": "Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C (2005a) Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease. Thromb Res 116:491–497",
      "volume": "116",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.amjcard.2005.06.039",
      "author": "DJ Angiolillo",
      "doi-asserted-by": "crossref",
      "first-page": "1095",
      "journal-title": "Am J Cardiol",
      "key": "1130_CR4",
      "unstructured": "Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C (2005b) Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene. Am J Cardiol 96:1095–1099",
      "volume": "96",
      "year": "2005"
    },
    {
      "DOI": "10.1161/01.ATV.0000223867.25324.1a",
      "author": "DJ Angiolillo",
      "doi-asserted-by": "crossref",
      "first-page": "1895",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "1130_CR5",
      "unstructured": "Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C (2006) Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel. Arterioscler Thromb Vasc Biol 26:1895–1900",
      "volume": "26",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.jacc.2006.11.044",
      "author": "DJ Angiolillo",
      "doi-asserted-by": "crossref",
      "first-page": "1505",
      "journal-title": "J Am Coll Cardiol",
      "key": "1130_CR6",
      "unstructured": "Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA (2007) Variability in individual responsiveness to clopidogrel clinical implications, management, and future perspectives. J Am Coll Cardiol 49:1505–1516",
      "volume": "49",
      "year": "2007"
    },
    {
      "DOI": "10.1136/bmj.d4588",
      "doi-asserted-by": "crossref",
      "key": "1130_CR7",
      "unstructured": "Bauer T, Bouman HJ, van Werkum JW, Ford NF, ten Berg JM, Taubert D (2011) Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis. BMJ 343 (in press)"
    },
    {
      "DOI": "10.1161/01.CIR.102.6.624",
      "author": "ME Bertrand",
      "doi-asserted-by": "crossref",
      "first-page": "624",
      "journal-title": "Circulation",
      "key": "1130_CR8",
      "unstructured": "Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH, Investigators FT (2000) Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 102:624–629",
      "volume": "102",
      "year": "2000"
    },
    {
      "DOI": "10.1056/NEJMoa060989",
      "author": "DL Bhatt",
      "doi-asserted-by": "crossref",
      "first-page": "1706",
      "journal-title": "N Engl J Med",
      "key": "1130_CR9",
      "unstructured": "Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ, CHARISMA Investigators (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354:1706–1717",
      "volume": "354",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.thromres.2009.10.014",
      "author": "L Bonello",
      "doi-asserted-by": "crossref",
      "first-page": "e167",
      "journal-title": "Thromb Res",
      "key": "1130_CR10",
      "unstructured": "Bonello L, Bonello-Palot N, Armero S, Bonello C, Mokhtar OA, Arques S, Dignat-George F, Camoin-Jau L, Paganelli F (2010a) Impact of P2Y12-ADP receptor polymorphism on the efficacy of clopidogrel dose-adjustment according to platelet reactivity monitoring in coronary artery disease patients. Thromb Res 125:e167–e170",
      "volume": "125",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.jacc.2010.07.004",
      "author": "L Bonello",
      "doi-asserted-by": "crossref",
      "first-page": "1630",
      "journal-title": "J Am Coll Cardiol",
      "key": "1130_CR11",
      "unstructured": "Bonello L, Armero S, Ait Mokhtar O, Mancini J, Aldebert P, Saut N, Bonello N, Barragan P, Arques S, Giacomoni MP, Bonello-Burignat C, Bartholomei MN, Dignat-George F, Camoin-Jau L, Paganelli F (2010b) Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19*2 loss of function polymorphism. J Am Coll Cardiol 56:1630–1636",
      "volume": "56",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nm.2281",
      "author": "HJ Bouman",
      "doi-asserted-by": "crossref",
      "first-page": "110",
      "journal-title": "Nat Med",
      "key": "1130_CR12",
      "unstructured": "Bouman HJ, Schömig E, van Werkum JW, Velder J, Hackeng CM, Hirschhäuser C, Waldmann C, Schmalz HG, ten Berg JM, Taubert D (2011) Paraoxonase-1 is a major determinant of clopidogrel efficacy. Nat Med 17:110–116",
      "volume": "17",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1538-7836.2007.02775.x",
      "author": "JT Brandt",
      "doi-asserted-by": "crossref",
      "first-page": "2429",
      "journal-title": "J Thromb Haemost",
      "key": "1130_CR13",
      "unstructured": "Brandt JT, Close SL, Iturria SJ, Payne CD, Farid NA, Ernest CS 2nd, Lachno DR, Salazar D, Winters KJ (2007) Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel. J Thromb Haemost 5:2429–2436",
      "volume": "5",
      "year": "2007"
    },
    {
      "DOI": "10.1001/jama.2010.181",
      "author": "NJ Breet",
      "doi-asserted-by": "crossref",
      "first-page": "754",
      "journal-title": "JAMA",
      "key": "1130_CR14",
      "unstructured": "Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ruven HJ, Bal ET, Deneer VH, Harmsze AM, van der Heyden JA, Rensing BJ, Suttorp MJ, Hackeng CM, ten Berg JM (2010) Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 303:754–762",
      "volume": "303",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.jacc.2007.01.094",
      "author": "P Buonamici",
      "doi-asserted-by": "crossref",
      "first-page": "2312",
      "journal-title": "J Am Coll Cardiol",
      "key": "1130_CR15",
      "unstructured": "Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, Moschi G, Gori AM, Abbate R, Antoniucci D (2007) Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 49:2312–2317",
      "volume": "49",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1538-7836.2006.02113.x",
      "author": "A Bura",
      "doi-asserted-by": "crossref",
      "first-page": "2096",
      "journal-title": "J Thromb Haemost",
      "key": "1130_CR16",
      "unstructured": "Bura A, Bachelot-Loza C, Ali FD, Aiach M, Gaussem P (2006) Role of the P2Y12 gene polymorphism in platelet responsiveness to clopidogrel in healthy subjects. J Thromb Haemost 4:2096–2097",
      "volume": "4",
      "year": "2006"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.106.661751",
      "author": "F Cambien",
      "doi-asserted-by": "crossref",
      "first-page": "1714",
      "journal-title": "Circulation",
      "key": "1130_CR17",
      "unstructured": "Cambien F, Tiret L (2007) Genetics of cardiovascular diseases: from single mutations to the whole genome. Circulation 116:1714–1724",
      "volume": "116",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.jacc.2010.12.047",
      "author": "G Campo",
      "doi-asserted-by": "crossref",
      "first-page": "2474",
      "journal-title": "J Am Coll Cardiol",
      "key": "1130_CR18",
      "unstructured": "Campo G, Parrinello G, Ferraresi P, Lunghi B, Tebaldi M, Miccoli M, Marchesini J, Bernardi F, Ferrari R, Valgimigli M (2011a) Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. J Am Coll Cardiol 57:2474–2483",
      "volume": "57",
      "year": "2011"
    },
    {
      "DOI": "10.3109/09537104.2011.579648",
      "author": "G Campo",
      "doi-asserted-by": "crossref",
      "first-page": "399",
      "journal-title": "Platelets",
      "key": "1130_CR19",
      "unstructured": "Campo G, Miccoli M, Tebaldi M, Marchesini J, Fileti L, Monti M, Valgimigli M, Ferrari R (2011b) Genetic determinants of on-clopidogrel high platelet reactivity. Platelets 22:399–407",
      "volume": "22",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nm.2386",
      "author": "J Camps",
      "doi-asserted-by": "crossref",
      "first-page": "1041",
      "journal-title": "Nat Med",
      "key": "1130_CR20",
      "unstructured": "Camps J, Joven J, Mackness B, Mackness M, Tawfik D, Draganov D, Costa LG, Paragh G, Seres I, Horke S, James R, Hernández A, Reddy S, Shih D, Navab M, Rochu D, Aviram M (2011) Paraoxonase-1 and clopidogrel efficacy. Nat Med 17:1041–1042",
      "volume": "17",
      "year": "2011"
    },
    {
      "author": "H Caplain",
      "first-page": "25",
      "issue": "suppl 2",
      "journal-title": "Semin Thromb Hemost",
      "key": "1130_CR21",
      "unstructured": "Caplain H, Donat F, Gaud C, Necciari J (1999) Pharmacokinetics of clopidogrel. Semin Thromb Hemost 25(suppl 2):25–28",
      "volume": "25",
      "year": "1999"
    },
    {
      "DOI": "10.1001/jama.2011.1529",
      "author": "G Cayla",
      "doi-asserted-by": "crossref",
      "first-page": "1765",
      "journal-title": "JAMA",
      "key": "1130_CR22",
      "unstructured": "Cayla G, Hulot JS, O’Connor SA, Pathak A, Scott SA, Gruel Y, Silvain J, Vignalou JB, Huerre Y, de la Briolle A, Allanic F, Beygui F, Barthélémy O, Montalescot G, Collet JP (2011) Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis. JAMA 306:1765–1774",
      "volume": "306",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S0140-6736(05)67660-X",
      "author": "ZM Chen",
      "doi-asserted-by": "crossref",
      "first-page": "1607",
      "journal-title": "Lancet",
      "key": "1130_CR23",
      "unstructured": "Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, Collins R, Liu LS, for the COMMIT Collaborative Group (2005) Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366:1607–1621",
      "volume": "366",
      "year": "2005"
    },
    {
      "DOI": "10.1126/science.1099870",
      "author": "JC Cohen",
      "doi-asserted-by": "crossref",
      "first-page": "869",
      "journal-title": "Science",
      "key": "1130_CR24",
      "unstructured": "Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH (2004) Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305:869–872",
      "volume": "305",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0140-6736(08)61845-0",
      "author": "JP Collet",
      "doi-asserted-by": "crossref",
      "first-page": "309",
      "journal-title": "Lancet",
      "key": "1130_CR25",
      "unstructured": "Collet JP, Hulot JS, Pena A, Villard E, Esteve JB, Silvain J, Payot L, Brugier D, Cayla G, Beygui F, Bensimon G, Funck-Brentano C, Montalescot G (2009) Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet 373:309–317",
      "volume": "373",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.jcin.2011.03.002",
      "author": "JP Collet",
      "doi-asserted-by": "crossref",
      "first-page": "392",
      "journal-title": "JACC Cardiovasc Interv",
      "key": "1130_CR26",
      "unstructured": "Collet JP, Hulot JS, Anzaha G, CLOVIS-2 Investigators (2011) High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2). JACC Cardiovasc Interv 4:392–402",
      "volume": "4",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1538-7836.2010.03809.x",
      "author": "C Combescure",
      "doi-asserted-by": "crossref",
      "first-page": "923",
      "journal-title": "J Thromb Haemost",
      "key": "1130_CR27",
      "unstructured": "Combescure C, Fontana P, Mallouk N, Berdague P, Labruyere C, Barazer I, Gris JC, Laporte S, Fabbro-Peray P, Reny JL, CLOpidogrel and Vascular ISchemic Events Meta-analysis Study Group (2010) Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis. J Thromb Haemost 8:923–933",
      "volume": "8",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1538-7836.2005.01751.x",
      "author": "T Cuisset",
      "doi-asserted-by": "crossref",
      "first-page": "542",
      "journal-title": "J Thromb Haemost",
      "key": "1130_CR28",
      "unstructured": "Cuisset T, Frere C, Quilici J, Barbou F, Morange PE, Hovasse T, Bonnet JL, Alessi MC (2006) High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost 4:542–549",
      "volume": "4",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.thromres.2007.01.012",
      "author": "T Cuisset",
      "doi-asserted-by": "crossref",
      "first-page": "893",
      "journal-title": "Thromb Res",
      "key": "1130_CR29",
      "unstructured": "Cuisset T, Frere C, Quilici J, Morange PE, Saut N, Lambert M, Camoin L, Vague IJ, Bonnet JL, Alessi MC (2007a) Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome. Thromb Res 120:893–899",
      "volume": "120",
      "year": "2007"
    },
    {
      "DOI": "10.1160/TH06-10-0583",
      "author": "T Cuisset",
      "doi-asserted-by": "crossref",
      "first-page": "212",
      "journal-title": "Thromb Haemost",
      "key": "1130_CR30",
      "unstructured": "Cuisset T, Frere C, Quilici J, Morange PE, Saut N, Romero-Barra M, Camoin L, Lambert M, Juhan-Vague I, Bonnet JL, Alessi MC (2007b) Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome. Thromb Haemost 97:212–217",
      "volume": "97",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.amjcard.2008.02.054",
      "author": "T Cuisset",
      "doi-asserted-by": "crossref",
      "first-page": "1700",
      "journal-title": "Am J Cardiol",
      "key": "1130_CR31",
      "unstructured": "Cuisset T, Hamilos M, Sarma J, Sarno G, Wyffels E, Vanderheyden M, Barbato E, Bartunek J, de Bruyne B, Wijns W (2008) Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. Am J Cardiol 101:1700–1703",
      "volume": "101",
      "year": "2008"
    },
    {
      "DOI": "10.4244/51",
      "author": "T Cuisset",
      "doi-asserted-by": "crossref",
      "first-page": "325",
      "journal-title": "EuroIntervention",
      "key": "1130_CR32",
      "unstructured": "Cuisset T, Cayla G, Frere C, Quilici J, Poyet R, Gaborit B, Bali L, Morange PE, Alessi MC, Bonnet JL (2009) Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment? EuroIntervention 5:325–329",
      "volume": "5",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nm.2367",
      "author": "T Cuisset",
      "doi-asserted-by": "crossref",
      "first-page": "1039",
      "issue": "9",
      "journal-title": "Nat Med",
      "key": "1130_CR33",
      "unstructured": "Cuisset T, Morange PE, Quilici J, Bonnet JL, Gachet C, Alessi MC (2011a) Paraoxonase-1 and clopidogrel efficacy. Nat Med 17(9):1039",
      "volume": "17",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.amjcard.2011.05.045",
      "doi-asserted-by": "crossref",
      "key": "1130_CR34",
      "unstructured": "Cuisset T, Quilici J, Cohen W, Fourcade L, Saut N, Pankert M, Gaborit B, Carrieri P, Morange PE, Bonnet JL, Alessi MC (2011) Usefulness of high clopidogrel maintenance dose according to CYP2C19 genotypes in clopidogrel low responders undergoing coronary stenting for non ST elevation acute coronary syndrome. Am J Cardiol (in press)"
    },
    {
      "DOI": "10.1038/nm.2436",
      "author": "PM Dansette",
      "doi-asserted-by": "crossref",
      "first-page": "1040",
      "journal-title": "Nat Med",
      "key": "1130_CR35",
      "unstructured": "Dansette PM, Rosi J, Bertho G, Mansuy D (2011) Paraoxonase-1 and clopidogrel efficacy. Nat Med 17:1040–1041",
      "volume": "17",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S0140-6736(04)16721-4",
      "author": "HC Diener",
      "doi-asserted-by": "crossref",
      "first-page": "331",
      "journal-title": "Lancet",
      "key": "1130_CR36",
      "unstructured": "Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ, on behalf of the MATCH Investigators (2004) Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364:331–337",
      "volume": "364",
      "year": "2004"
    },
    {
      "DOI": "10.1172/JCI20986",
      "author": "RT Dorsam",
      "doi-asserted-by": "crossref",
      "first-page": "340",
      "journal-title": "J Clin Invest",
      "key": "1130_CR37",
      "unstructured": "Dorsam RT, Kunapuli SP (2004) Central role of the P2Y12 receptor in platelet activation. J Clin Invest 113:340–345",
      "volume": "113",
      "year": "2004"
    },
    {
      "DOI": "10.1111/j.1538-7836.2007.02722.x",
      "author": "P Fontana",
      "doi-asserted-by": "crossref",
      "first-page": "2153",
      "journal-title": "J Thromb Haemost",
      "key": "1130_CR38",
      "unstructured": "Fontana P, Hulot JS, De Moerloose P, Gaussem P (2007) Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects. J Thromb Haemost 5:2153–2155",
      "volume": "5",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1538-7836.2011.04409.x",
      "author": "P Fontana",
      "doi-asserted-by": "crossref",
      "first-page": "1664",
      "journal-title": "J Thromb Haemost",
      "key": "1130_CR39",
      "unstructured": "Fontana P, James R, Barazer I, Berdagué P, Schved JF, Rebsamen M, Vuilleumier N (2011) Clopidogrel responsiveness in the ADRIE study. J Thromb Haemost 9:1664–1666",
      "volume": "9",
      "year": "2011"
    },
    {
      "DOI": "10.1160/TH07-04-0296",
      "author": "C Frere",
      "doi-asserted-by": "crossref",
      "first-page": "838",
      "journal-title": "Thromb Haemost",
      "key": "1130_CR40",
      "unstructured": "Frere C, Cuisset T, Quilici J, Camoin L, Carvajal J, Morange PE, Lambert M, Juhan-Vague I, Bonnet JL, Alessi MC (2007) ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thromb Haemost 98:838–843",
      "volume": "98",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.amjcard.2007.11.065",
      "author": "C Frere",
      "doi-asserted-by": "crossref",
      "first-page": "1088",
      "journal-title": "Am J Cardiol",
      "key": "1130_CR41",
      "unstructured": "Frere C, Cuisset T, Morange PE, Quilici J, Camoin-Jau L, Saut N, Faille D, Lambert M, Juhan-Vague I, Bonnet JL, Alessi MC (2008) Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome. Am J Cardiol 101:1088–1093",
      "volume": "101",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1538-7836.2009.03500.x",
      "author": "C Frere",
      "doi-asserted-by": "crossref",
      "first-page": "1409",
      "journal-title": "J Thromb Haemost",
      "key": "1130_CR42",
      "unstructured": "Frere C, Cuisset T, Gaborit B, Alessi MC, Hulot JS (2009) The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome. J Thromb Haemost 7:1409–1411",
      "volume": "7",
      "year": "2009"
    },
    {
      "author": "V Fuster",
      "first-page": "1147",
      "issue": "Suppl 3",
      "journal-title": "Circulation",
      "key": "1130_CR43",
      "unstructured": "Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH (1990) Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 82(Suppl 3):1147–1159",
      "volume": "82",
      "year": "1990"
    },
    {
      "DOI": "10.1093/eurheartj/ehl275",
      "author": "T Geisler",
      "doi-asserted-by": "crossref",
      "first-page": "2420",
      "journal-title": "Eur Heart J",
      "key": "1130_CR44",
      "unstructured": "Geisler T, Langer H, Wydymus M, Göhring K, Zürn C, Bigalke B, Stellos K, May AE, Gawaz M (2006) Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 27:2420–2425",
      "volume": "27",
      "year": "2006"
    },
    {
      "DOI": "10.2217/14622416.9.9.1251",
      "author": "T Geisler",
      "doi-asserted-by": "crossref",
      "first-page": "1251",
      "journal-title": "Pharmacogenomics",
      "key": "1130_CR45",
      "unstructured": "Geisler T, Schaeffeler E, Dippon J, Winter S, Buse V, Bischofs C, Zuern C, Moerike K, Gawaz M, Schwab M (2008) CYP2C19 and non genetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation. Pharmacogenomics 9:1251–1259",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1097/FPC.0b013e3282f1b2be",
      "author": "B Giusti",
      "doi-asserted-by": "crossref",
      "first-page": "1057",
      "journal-title": "Pharmacogenet Genomics",
      "key": "1130_CR46",
      "unstructured": "Giusti B, Gori AM, Marcucci R, Saracini C, Sestini I, Paniccia R, Valente S, Antoniucci D, Abbate R, Gensini GF (2007) Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients. Pharmacogenet Genomics 17:1057–1064",
      "volume": "17",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.atherosclerosis.2006.11.009",
      "author": "B Giusti",
      "doi-asserted-by": "crossref",
      "first-page": "341",
      "journal-title": "Atherosclerosis",
      "key": "1130_CR47",
      "unstructured": "Giusti B, Gori AM, Marcucci R, Sestini I, Saracini C, Paniccia R, Poli S, Giglioli C, Valente S, Prisco D, Gensini GF, Abbate R (2008) Role of glycoprotein Ia gene polymorphisms in determining platelet function in myocardial infarction patients undergoing percutaneous coronary intervention on dual antiplatelet treatment. Atherosclerosis 196:341–348",
      "volume": "196",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.amjcard.2008.11.048",
      "author": "B Giusti",
      "doi-asserted-by": "crossref",
      "first-page": "806",
      "journal-title": "Am J Cardiol",
      "key": "1130_CR48",
      "unstructured": "Giusti B, Gori AM, Marcucci R, Saracini C, Sestini L, Paniccia R, Buonamici P, Antoniucci D, Abbate R, Gensini GF (2009) Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis. Am J Cardiol 103:806–811",
      "volume": "103",
      "year": "2009"
    },
    {
      "DOI": "10.1093/eurheartj/ehq321",
      "author": "AM Harmsze",
      "doi-asserted-by": "crossref",
      "first-page": "3046",
      "journal-title": "Eur Heart J",
      "key": "1130_CR49",
      "unstructured": "Harmsze AM, van Werkum JW, Ten Berg JM, Zwart B, Bouman HJ, Breet NJ, van ‘t Hof AW, Ruven HJ, Hackeng CM, Klungel OH, de Boer A, Deneer VH (2010) CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case–control study. Eur Heart J 31:3046–3053",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.jacc.2006.06.065",
      "author": "W Hochholzer",
      "doi-asserted-by": "crossref",
      "first-page": "1742",
      "journal-title": "J Am Coll Cardiol",
      "key": "1130_CR50",
      "unstructured": "Hochholzer W, Trenk D, Bestehorn HP, Fischer B, Valina CM, Ferenc M, Gick M, Caputo A, Büttner HJ, Neumann FJ (2006) Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 48:1742–1750",
      "volume": "48",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.jacc.2010.02.031",
      "author": "W Hochholzer",
      "doi-asserted-by": "crossref",
      "first-page": "2427",
      "journal-title": "J Am Coll Cardiol",
      "key": "1130_CR51",
      "unstructured": "Hochholzer W, Trenk D, Fromm MF, Valina CM, Stratz C, Bestehorn HP, Büttner HJ, Neumann FJ (2010) Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement. J Am Coll Cardiol 55:2427–2434",
      "volume": "55",
      "year": "2010"
    },
    {
      "DOI": "10.1182/blood-2006-04-013052",
      "author": "JS Hulot",
      "doi-asserted-by": "crossref",
      "first-page": "2244",
      "journal-title": "Blood",
      "key": "1130_CR52",
      "unstructured": "Hulot JS, Bura A, Villard E, Azizi M, Remones V, Goyenvalle C, Aiach M, Lechat P, Gaussem P (2006) Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects. Blood 108:2244–2247",
      "volume": "108",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.jacc.2009.12.071",
      "author": "JS Hulot",
      "doi-asserted-by": "crossref",
      "first-page": "134",
      "journal-title": "J Am Coll Cardiol",
      "key": "1130_CR53",
      "unstructured": "Hulot JS, Collet JP, Silvain J, Pena A, Bellemain-Appaix A, Barthélémy O, Cayla G, Beygui F, Montalescot G (2010) Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis. J Am Coll Cardiol 56:134–143",
      "volume": "56",
      "year": "2010"
    },
    {
      "DOI": "10.1161/CIRCINTERVENTIONS.111.963025",
      "author": "JS Hulot",
      "doi-asserted-by": "crossref",
      "first-page": "422",
      "journal-title": "Circ Cardiovasc Interv",
      "key": "1130_CR54",
      "unstructured": "Hulot JS, Collet JP, Cayla G, Silvain J, Allanic F, Bellemain-Appaix A, Scott SA, Montalescot G (2011a) CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patients. Circ Cardiovasc Interv 4:422–428",
      "volume": "4",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S0140-6736(11)60227-4",
      "author": "JS Hulot",
      "doi-asserted-by": "crossref",
      "first-page": "637",
      "journal-title": "Lancet",
      "key": "1130_CR55",
      "unstructured": "Hulot JS, Collet JP, Montalescot G (2011b) Genetic substudy of the PLATO trial. Lancet 377:637",
      "volume": "377",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.pharmthera.2007.09.004",
      "author": "M Ingelman-Sundberg",
      "doi-asserted-by": "crossref",
      "first-page": "496",
      "journal-title": "Pharmacol Ther",
      "key": "1130_CR56",
      "unstructured": "Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C (2007) Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496–526",
      "volume": "116",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.pharmthera.2004.11.001",
      "author": "AD Johnson",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "journal-title": "Pharmacol Ther",
      "key": "1130_CR57",
      "unstructured": "Johnson AD, Wang D, Sadee W (2005) Polymorphisms affecting gene regulation and RNA processing: broad implications for pharmacogenetics. Pharmacol Ther 106:19–38",
      "volume": "106",
      "year": "2005"
    },
    {
      "author": "A Kurihara",
      "first-page": "99",
      "issue": "Suppl. 2",
      "journal-title": "Drug Metab Rev",
      "key": "1130_CR58",
      "unstructured": "Kurihara A, Hagihara K, Kazui M, Ishizuka T, Farid NA, Ikeda T (2005) In vitro metabolism of antiplatelet agent clopidogrel: cytochrome P450 isoforms responsible for two oxidation steps involved in active metabolite formation. Drug Metab Rev 37(Suppl. 2):99",
      "volume": "37",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.thromres.2006.02.006",
      "author": "EI Lev",
      "doi-asserted-by": "crossref",
      "first-page": "355",
      "journal-title": "Thromb Res",
      "key": "1130_CR59",
      "unstructured": "Lev EI, Patel RT, Guthikonda S, Lopez D, Bray PF, Kleiman NS (2007) Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel. Thromb Res 119:355–360",
      "volume": "119",
      "year": "2007"
    },
    {
      "DOI": "10.1038/clpt.2011.194",
      "author": "JP Lewis",
      "doi-asserted-by": "crossref",
      "first-page": "568",
      "journal-title": "Clin Pharmacol Ther",
      "key": "1130_CR60",
      "unstructured": "Lewis JP, Fisch AS, Ryan K, O’Connell JR, Gibson Q, Mitchell BD, Shen H, Tanner K, Horenstein RB, Pakzy R, Tantry US, Bliden KP, Gurbel PA, Shuldiner AR (2011) Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response. Clin Pharmacol Ther 90:568–574",
      "volume": "90",
      "year": "2011"
    },
    {
      "author": "R Lins",
      "first-page": "29",
      "issue": "Suppl. 2",
      "journal-title": "Semin Thromb Hemost",
      "key": "1130_CR61",
      "unstructured": "Lins R, Broekhuysen J, Necciari J, Deroubaix X (1999) Pharmacokinetic profile of 14C-labeled clopidogrel. Semin Thromb Hemost 25(Suppl. 2):29–33",
      "volume": "25",
      "year": "1999"
    },
    {
      "DOI": "10.1111/j.1365-2125.2009.03578.x",
      "author": "A Li-Wan-Po",
      "doi-asserted-by": "crossref",
      "first-page": "222",
      "journal-title": "Br J Clin Pharmacol",
      "key": "1130_CR62",
      "unstructured": "Li-Wan-Po A, Girard T, Farndon P, Cooley C, Lithgow J (2010) Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17. Br J Clin Pharmacol 69:222–230",
      "volume": "69",
      "year": "2010"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.108.812636",
      "author": "R Marcucci",
      "doi-asserted-by": "crossref",
      "first-page": "237",
      "journal-title": "Circulation",
      "key": "1130_CR63",
      "unstructured": "Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF (2009) Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Circulation 119:237–242",
      "volume": "119",
      "year": "2009"
    },
    {
      "DOI": "10.1161/01.CIR.0000130846.46168.03",
      "author": "S Matetzky",
      "doi-asserted-by": "crossref",
      "first-page": "3171",
      "journal-title": "Circulation",
      "key": "1130_CR64",
      "unstructured": "Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, Hod H (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109:3171–3175",
      "volume": "109",
      "year": "2004"
    },
    {
      "DOI": "10.1056/NEJMoa0809171",
      "author": "JL Mega",
      "doi-asserted-by": "crossref",
      "first-page": "354",
      "journal-title": "N Engl J Med",
      "key": "1130_CR65",
      "unstructured": "Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS (2009a) Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 360:354–362",
      "volume": "360",
      "year": "2009"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.109.851949",
      "author": "JL Mega",
      "doi-asserted-by": "crossref",
      "first-page": "2553",
      "journal-title": "Circulation",
      "key": "1130_CR66",
      "unstructured": "Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias WL, Braunwald E, Sabatine MS (2009b) Cytochrome p450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 119:2553–2560",
      "volume": "119",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S0140-6736(10)61273-1",
      "author": "JL Mega",
      "doi-asserted-by": "crossref",
      "first-page": "1312",
      "journal-title": "Lancet",
      "key": "1130_CR67",
      "unstructured": "Mega JL, Close SL, Wiviott SD, Shen L, Walker JR, Simon T, Antman EM, Braunwald E, Sabatine MS (2010a) Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. Lancet 376:1312–1319",
      "volume": "376",
      "year": "2010"
    },
    {
      "DOI": "10.1001/jama.2010.1543",
      "author": "JL Mega",
      "doi-asserted-by": "crossref",
      "first-page": "1821",
      "journal-title": "JAMA",
      "key": "1130_CR68",
      "unstructured": "Mega JL, Simon T, Collet JP, Anderson JL, Antman EM, Bliden K, Cannon CP, Danchin N, Giusti B, Gurbel P, Horne BD, Hulot JS, Kastrati A, Montalescot G, Neumann FJ, Shen L, Sibbing D, Steg PG, Trenk D, Wiviott SD, Sabatine MS (2010b) Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA 304:1821–1830",
      "volume": "304",
      "year": "2010"
    },
    {
      "DOI": "10.1016/S0140-6736(01)05701-4",
      "author": "SR Mehta",
      "doi-asserted-by": "crossref",
      "first-page": "527",
      "journal-title": "Lancet",
      "key": "1130_CR69",
      "unstructured": "Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA, Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358:527–533",
      "volume": "358",
      "year": "2001"
    },
    {
      "DOI": "10.2165/00002512-200724040-00006",
      "author": "E Papp",
      "doi-asserted-by": "crossref",
      "first-page": "345",
      "journal-title": "Drugs Aging",
      "key": "1130_CR70",
      "unstructured": "Papp E, Havasi V, Bene J, Komlosi K, Talian G, Feher G, Horvath B, Szapary L, Toth K, Melegh B (2007) Does glycoprotein IIIa gene (Pl(A)) polymorphism influence clopidogrel resistance?: a study in older patients. Drugs Aging 24:345–350",
      "volume": "24",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJMoa1008410",
      "author": "G Paré",
      "doi-asserted-by": "crossref",
      "first-page": "1704",
      "journal-title": "N Engl J Med",
      "key": "1130_CR71",
      "unstructured": "Paré G, Mehta SR, Yusuf S, Anand SS, Connolly SJ, Hirsh J, Simonsen K, Bhatt DL, Fox KA, Eikelboom JW (2010) Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med 363:1704–1714",
      "volume": "363",
      "year": "2010"
    },
    {
      "DOI": "10.1093/eurheartj/ehn046",
      "author": "MJ Price",
      "doi-asserted-by": "crossref",
      "first-page": "992",
      "journal-title": "Eur Heart J",
      "key": "1130_CR72",
      "unstructured": "Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP, Ernst A, Sawhney NS, Schatz RA, Teirstein PS (2008) Prognostic significance of postclopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 29:992–1000",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.2217/pgs.11.73",
      "author": "O Rideg",
      "doi-asserted-by": "crossref",
      "first-page": "1269",
      "journal-title": "Pharmacogenomics",
      "key": "1130_CR73",
      "unstructured": "Rideg O, Komócsi A, Magyarlaki T, Tokés-Füzesi M, Miseta A, Kovács GL, Aradi D (2011) Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention. Pharmacogenomics 12:1269–1280",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1161/CIRCGENETICS.109.861799",
      "author": "G Rudez",
      "doi-asserted-by": "crossref",
      "first-page": "515",
      "journal-title": "Circ Cardiovasc Genet",
      "key": "1130_CR74",
      "unstructured": "Rudez G, Bouman HJ, van Werkum JW, Leebeek FW, Kruit A, Ruven HJ, ten Berg JM, de Maat MP, Hackeng CM (2009) Common variation in the platelet receptor P2RY12 gene is associated with residual on-clopidogrel platelet reactivity in patients undergoing elective percutaneous coronary interventions. Circ Cardiovasc Genet 2:515–521",
      "volume": "2",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMoa050522",
      "doi-asserted-by": "crossref",
      "key": "1130_CR75",
      "unstructured": "Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E, for the CLARITY TIMI 28 Investigators (2005) Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352:1179–1189"
    },
    {
      "DOI": "10.1055/s-2005-869523",
      "author": "P Savi",
      "doi-asserted-by": "crossref",
      "first-page": "174",
      "journal-title": "Semin Thromb Hemost",
      "key": "1130_CR76",
      "unstructured": "Savi P, Herbert JM (2005) Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin Thromb Hemost 31:174–183",
      "volume": "31",
      "year": "2005"
    },
    {
      "DOI": "10.1055/s-0037-1614133",
      "author": "P Savi",
      "doi-asserted-by": "crossref",
      "first-page": "891",
      "journal-title": "Thromb Haemost",
      "key": "1130_CR77",
      "unstructured": "Savi P, Pereillo JM, Uzabiaga MF, Combalbert J, Picard C, Maffrand JP, Pascal M, Herbert JM (2000) Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost 84:891–896",
      "volume": "84",
      "year": "2000"
    },
    {
      "DOI": "10.1253/circj.CJ-10-0525",
      "doi-asserted-by": "crossref",
      "key": "1130_CR1000",
      "unstructured": "Sawada T, Shinke T, Shite J, Honjo T, Haraguchi Y, Nishio R, Shinohara M, Toh R, Ishida T, Kawamori H, Kozuki A, Inoue T, Hariki H, Hirata K (2010) Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel. Circ J 75:99–105"
    },
    {
      "DOI": "10.1001/jama.2009.1232",
      "author": "AR Shuldiner",
      "doi-asserted-by": "crossref",
      "first-page": "849",
      "journal-title": "JAMA",
      "key": "1130_CR78",
      "unstructured": "Shuldiner AR, O’Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB, Damcott CM, Pakyz R, Tantry US, Gibson Q, Pollin TI, Post W, Parsa A, Mitchell BD, Faraday N, Herzog W, Gurbel PA (2009) Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA 302:849–857",
      "volume": "302",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1538-7836.2006.01869.x",
      "author": "D Sibbing",
      "doi-asserted-by": "crossref",
      "first-page": "912",
      "journal-title": "J Thromb Haemost",
      "key": "1130_CR79",
      "unstructured": "Sibbing D, von Beckerath O, Schömig A, Kastrati A, von Beckerath N (2006) P2Y1 gene A1622G dimorphism is not associated with adenosine diphosphate-induced platelet activation and aggregation after administration of a single high dose of clopidogrel. J Thromb Haemost 4:912–914",
      "volume": "4",
      "year": "2006"
    },
    {
      "DOI": "10.1093/eurheartj/ehp041",
      "author": "D Sibbing",
      "doi-asserted-by": "crossref",
      "first-page": "916",
      "journal-title": "Eur Heart J",
      "key": "1130_CR80",
      "unstructured": "Sibbing D, Stegherr J, Latz W, Koch W, Mehilli J, Dörrler K, Morath T, Schömig A, Kastrati A, von Beckerath N (2009) Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention. Eur Heart J 30:916–922",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1538-7836.2009.03709.x",
      "author": "D Sibbing",
      "doi-asserted-by": "crossref",
      "first-page": "250",
      "journal-title": "J Thromb Haemost",
      "key": "1130_CR81",
      "unstructured": "Sibbing D, Schulz S, Braun S, Morath T, Stegherr J, Mehilli J, Schömig A, von Beckerath N, Kastrati A (2010a) Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost 8:250–256",
      "volume": "8",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1538-7836.2010.03921.x",
      "author": "D Sibbing",
      "doi-asserted-by": "crossref",
      "first-page": "1685",
      "journal-title": "J Thromb Haemost",
      "key": "1130_CR82",
      "unstructured": "Sibbing D, Gebhard D, Koch W, Braun S, Stegherr J, Morath T, Von Beckerath N, Mehilli J, Schömig A, Schuster T, Kastrati A (2010b) Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy. J Thromb Haemost 8:1685–1693",
      "volume": "8",
      "year": "2010"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.109.885194",
      "author": "D Sibbing",
      "doi-asserted-by": "crossref",
      "first-page": "512",
      "journal-title": "Circulation",
      "key": "1130_CR83",
      "unstructured": "Sibbing D, Koch W, Gebhard D, Schuster T, Braun S, Stegherr J, Morath T, Schomig A, Von Beckerath N, Kastrati A (2010c) Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement. Circulation 121:512–518",
      "volume": "121",
      "year": "2010"
    },
    {
      "DOI": "10.1093/eurheartj/ehr155",
      "author": "D Sibbing",
      "doi-asserted-by": "crossref",
      "first-page": "1605",
      "journal-title": "Eur Heart J",
      "key": "1130_CR84",
      "unstructured": "Sibbing D, Koch W, Massberg S, Byrne RA, Mehilli J, Schulz S, Mayer K, Bernlochner I, Schömig A, Kastrati A (2011) No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting. Eur Heart J 32:1605–1613",
      "volume": "32",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.clpt.2005.10.002",
      "author": "SC Sim",
      "doi-asserted-by": "crossref",
      "first-page": "103",
      "journal-title": "Clin Pharmacol Ther",
      "key": "1130_CR85",
      "unstructured": "Sim SC, Risinger C, Dahl ML, Aklillu E, Christensen M, Bertilsson L et al (2006) A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther 79:103–113",
      "volume": "79",
      "year": "2006"
    },
    {
      "DOI": "10.1056/NEJMoa0808227",
      "doi-asserted-by": "crossref",
      "key": "1130_CR86",
      "unstructured": "Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L for the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators (2009) Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 360:363–375"
    },
    {
      "DOI": "10.1080/00207230500120294",
      "author": "SM Smith",
      "doi-asserted-by": "crossref",
      "first-page": "340",
      "journal-title": "Platelets",
      "key": "1130_CR87",
      "unstructured": "Smith SM, Judge HM, Peters G, Armstrong M, Dupont A, Gaussem P, Storey RF (2005) PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy. Platelets 16:340–345",
      "volume": "16",
      "year": "2005"
    },
    {
      "DOI": "10.1080/09537100500475844",
      "author": "SM Smith",
      "doi-asserted-by": "crossref",
      "first-page": "250",
      "journal-title": "Platelets",
      "key": "1130_CR88",
      "unstructured": "Smith SM, Judge HM, Peters G, Armstrong M, Fontana P, Gaussem P, Daly ME, Storey RF (2006) Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy. Platelets 17:250–258",
      "volume": "17",
      "year": "2006"
    },
    {
      "DOI": "10.1038/tpj.2010.21",
      "author": "F Sofi",
      "doi-asserted-by": "crossref",
      "first-page": "199",
      "journal-title": "Pharmacogenomics J",
      "key": "1130_CR89",
      "unstructured": "Sofi F, Giusti B, Marcucci R, Gori AM, Abbate R, Gensini GF (2011) Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis. Pharmacogenomics J 11:199–206",
      "volume": "11",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.ijcard.2007.12.118",
      "author": "P Staritz",
      "doi-asserted-by": "crossref",
      "first-page": "341",
      "journal-title": "Int J Cardiol",
      "key": "1130_CR90",
      "unstructured": "Staritz P, Kurz K, Stoll M, Giannitsis E, Katus HA, Ivandic BT (2009) Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene. Int J Cardiol 133:341–345",
      "volume": "133",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jama.288.19.2411",
      "doi-asserted-by": "crossref",
      "key": "1130_CR91",
      "unstructured": "Steinhubl SR, Berger PB, Tift Mann J III, Fry ET, DeLago A, Wilmer C, Topol EJ, for the CREDO Investigators (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized controlled trial. JAMA 288:2411–2420"
    },
    {
      "DOI": "10.1080/09537100120085450",
      "author": "RF Storey",
      "doi-asserted-by": "crossref",
      "first-page": "443",
      "journal-title": "Platelets",
      "key": "1130_CR92",
      "unstructured": "Storey RF, Newby LJ, Heptinstall S (2001) Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood. Platelets 12:443–447",
      "volume": "12",
      "year": "2001"
    },
    {
      "DOI": "10.1080/17482940902785474",
      "author": "G Syros",
      "doi-asserted-by": "crossref",
      "first-page": "88",
      "journal-title": "Acute Card Care",
      "key": "1130_CR93",
      "unstructured": "Syros G, Mehran R, Weisz G, Kittas C, Moses JW, Leon M, Dangas G (2009) Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention. Acute Card Care 11:88–91",
      "volume": "11",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMoa0901301",
      "doi-asserted-by": "crossref",
      "key": "1130_CR94",
      "unstructured": "The ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S (2009) Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 360:2066-78"
    },
    {
      "DOI": "10.1016/j.ahj.2010.06.039",
      "author": "KA Tiroch",
      "doi-asserted-by": "crossref",
      "first-page": "506",
      "journal-title": "Am Heart J",
      "key": "1130_CR95",
      "unstructured": "Tiroch KA, Sibbing D, Koch W, Roosen-Runge T, Mehilli J, Schömig A, Kastrati A (2010) Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events. Am Heart J 160:506–512",
      "volume": "160",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.jacc.2007.12.056",
      "author": "D Trenk",
      "doi-asserted-by": "crossref",
      "first-page": "1925",
      "journal-title": "J Am Coll Cardiol",
      "key": "1130_CR96",
      "unstructured": "Trenk D, Hochholzer W, Fromm MF, Chialda LE, Pahl A, Valina CM, Stratz C, chmiebusch P, Bestehorn HP, Büttner HJ, Neumann FJ (2008) Cytochrome P450 2C19 681G_A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. J Am Coll Cardiol 51:1925–1934",
      "volume": "51",
      "year": "2008"
    },
    {
      "DOI": "10.1161/CIRCGENETICS.111.960112",
      "author": "D Trenk",
      "doi-asserted-by": "crossref",
      "first-page": "429",
      "journal-title": "Circ Cardiovasc Genet",
      "key": "1130_CR97",
      "unstructured": "Trenk D, Hochholzer W, Fromm MF, Zolk O, Valina CM, Stratz C, Neumann FJ (2011) Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement. Circ Cardiovasc Genet 4:429–436",
      "volume": "4",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1538-7836.2008.03050.x",
      "author": "K Umemura",
      "doi-asserted-by": "crossref",
      "first-page": "1439",
      "journal-title": "J Thromb Haemost",
      "key": "1130_CR98",
      "unstructured": "Umemura K, Furuta T, Kondo K (2008) The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects. J Thromb Haemost 6:1439–1441",
      "volume": "6",
      "year": "2008"
    },
    {
      "DOI": "10.1093/eurheartj/ehn416",
      "doi-asserted-by": "crossref",
      "key": "1130_CR99",
      "unstructured": "Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M; ESC Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Silber S, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29:2909–2945"
    },
    {
      "DOI": "10.1097/01.mbc.0000164429.21040.0a",
      "author": "N Beckerath von",
      "doi-asserted-by": "crossref",
      "first-page": "199",
      "journal-title": "Blood Coagul Fibrinolysis",
      "key": "1130_CR100",
      "unstructured": "von Beckerath N, von Beckerath O, Koch W, Eichinger M, Schömig A, Kastrati A (2005) P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose. Blood Coagul Fibrinolysis 16:199–204",
      "volume": "16",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S0140-6736(10)61274-3",
      "author": "L Wallentin",
      "doi-asserted-by": "crossref",
      "first-page": "1320",
      "journal-title": "Lancet",
      "key": "1130_CR101",
      "unstructured": "Wallentin L, James S, Storey RF, Armstrong M, Barratt BJ, Horrow J, Husted S, Katus H, Steg PG, Shah SH, Becker RC, PLATO investigators (2010) Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial. Lancet 376:1320–1328",
      "volume": "376",
      "year": "2010"
    },
    {
      "key": "1130_CR102",
      "unstructured": "Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P; EACTS Clinical Guidelines Committee, Kolh P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P; Document Reviewers, Kearney P, von Segesser L, Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov A, Eha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Pirk J, Rozenman Y, Sabate M, Starc R, Thielmann M, Wheatley DJ, Windecker S, Zembala M (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J (in press)"
    },
    {
      "DOI": "10.1016/S0169-409X(02)00076-5",
      "author": "HG Xie",
      "doi-asserted-by": "crossref",
      "first-page": "1257",
      "journal-title": "Adv Drug Deliv Rev",
      "key": "1130_CR103",
      "unstructured": "Xie HG, Prasad HC, Kim RB, Stein CM (2002) CYP2C9 allelic variants: ethnic distribution and functional significance. Adv Drug Deliv Rev 54:1257–1270",
      "volume": "54",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJMoa010746",
      "author": "S Yusuf",
      "doi-asserted-by": "crossref",
      "first-page": "494",
      "journal-title": "N Engl J Med",
      "key": "1130_CR104",
      "unstructured": "Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494–502",
      "volume": "345",
      "year": "2001"
    }
  ],
  "reference-count": 105,
  "references-count": 105,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-011-1130-6"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Recent advances in the pharmacogenetics of clopidogrel"
  ],
  "type": "journal-article",
  "volume": "131"
}